Malmgren Linnea, Grubb Anders
Department of Clinical Sciences Malmö, Clinical and Molecular Osteoporosis Research Unit, Lund University, Malmö, Sweden.
Department of Geriatrics, Skåne University Hospital, Malmö, Sweden.
Clin Kidney J. 2023 Apr 13;16(8):1206-1210. doi: 10.1093/ckj/sfad086. eCollection 2023 Aug.
In this issue of , Stehlé and colleagues demonstrate that estimation of glomerular filtration rate (GFR) by use of creatinine and a measure, total lumbar muscle cross-sectional area, reflecting the total muscle mass of an individual, is superior to GFR-estimating equations based upon creatinine and demographic variables. The report by Stehlé demonstrates one solution to the interference of muscle mass in the use of creatinine to estimate GFR. This interference was identified already at the start, in 1959, of using creatinine for estimation of GFR. Different ways of taking the muscle mass into account when creatinine-based estimations of GFR have been used generally include use of controversial race and sex coefficients. A new marker of GFR, cystatin C, introduced in 1979, has been shown to be virtually uninfluenced by muscle mass. In this editorial, the simultaneous use of creatinine and cystatin C to estimate GFR, muscle mass and selective glomerular hypofiltration syndromes is described.
在本期杂志中,斯特勒及其同事证明,利用肌酐以及一项反映个体肌肉总量的指标——腰椎肌肉总横截面积来估算肾小球滤过率(GFR),优于基于肌酐和人口统计学变量的GFR估算方程。斯特勒的报告展示了一种解决肌肉量对利用肌酐估算GFR产生干扰的方法。这种干扰在1959年刚开始使用肌酐估算GFR时就已被发现。在使用基于肌酐的GFR估算方法时,通常考虑肌肉量的不同方式包括使用存在争议的种族和性别系数。1979年引入的一种新的GFR标志物——胱抑素C,已被证明几乎不受肌肉量的影响。在这篇社论中,描述了同时使用肌酐和胱抑素C来估算GFR、肌肉量以及选择性肾小球滤过功能减退综合征的情况。